ALIGN TECHNOLOGY, INC. Accounts Receivable, Sale
ALIGN TECHNOLOGY, INC. (ALGN) reported Accounts Receivable, Sale of $7.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes
us-gaap:AccountsReceivableSale · last filed 2026-08-05
- ALIGN TECHNOLOGY, INC. accounts receivable, sale for the quarter ending 2026-06-30 was $7.00M, a 61.75% decline year-over-year.
- ALIGN TECHNOLOGY, INC. accounts receivable, sale for the quarter ending 2026-03-31 was $11.20M, a 75.00% increase year-over-year.
- ALIGN TECHNOLOGY, INC. accounts receivable, sale for the quarter ending 2025-12-31 was $13.30M, a 25.70% decline year-over-year.
- ALIGN TECHNOLOGY, INC. accounts receivable, sale for the quarter ending 2025-09-30 was $10.00M, a 21.95% increase year-over-year.
- ALIGN TECHNOLOGY, INC. accounts receivable, sale for fiscal 2025 was $47.90M, a 8.06% decline from fiscal 2024.
- ALIGN TECHNOLOGY, INC. accounts receivable, sale for fiscal 2024 was $52.10M, a 1.76% increase from fiscal 2023.
- ALIGN TECHNOLOGY, INC. accounts receivable, sale for fiscal 2023 was $51.20M, a 38.38% increase from fiscal 2022.
- ALIGN TECHNOLOGY, INC. accounts receivable, sale for fiscal 2022 was $37.00M.
| Period end | Accounts Receivable, Sale 3 month | Accounts Receivable, Sale 6 month | Accounts Receivable, Sale 9 month | Accounts Receivable, Sale 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.00M 10-Q · filed 2026-08-05 | $18.20M 10-Q · filed 2026-08-05 | $31.50M derived: sum of 3 quarters · filed 2026-08-05 | $41.50M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $11.20M 10-Q · filed 2026-05-06 | $24.50M derived: sum of 2 quarters · filed 2026-05-06 | $34.50M derived: sum of 3 quarters · filed 2026-05-06 | $52.80M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $13.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $23.30M derived: sum of 2 quarters · filed 2026-02-27 | $41.60M derived: sum of 3 quarters · filed 2026-08-05 | $47.90M 10-K · filed 2026-02-27 |
| 2025-09-30 | $10.00M 10-Q · filed 2025-11-05 | $28.30M derived: sum of 2 quarters · filed 2026-08-05 | $34.60M 10-Q · filed 2025-11-05 | $52.60M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $18.30M 10-Q · filed 2026-08-05 | $24.70M 10-Q · filed 2026-08-05 | $42.60M derived: sum of 3 quarters · filed 2026-08-05 | $50.80M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $6.40M 10-Q · filed 2026-05-06 | $24.30M derived: sum of 2 quarters · filed 2026-05-06 | $32.50M derived: sum of 3 quarters · filed 2026-05-06 | $43.80M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $17.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $26.10M derived: sum of 2 quarters · filed 2026-02-27 | $37.40M derived: sum of 3 quarters · filed 2026-02-27 | $52.10M 10-K · filed 2026-02-27 |
| 2024-09-30 | $8.20M 10-Q · filed 2025-11-05 | $19.50M derived: sum of 2 quarters · filed 2025-11-05 | $34.20M 10-Q · filed 2025-11-05 | $44.90M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $11.30M 10-Q · filed 2025-08-06 | $25.90M 10-Q · filed 2025-08-06 | $36.70M derived: sum of 3 quarters · filed 2025-08-06 | $60.90M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $14.60M 10-Q · filed 2025-05-08 | $25.40M derived: sum of 2 quarters · filed 2025-05-08 | $49.60M derived: sum of 3 quarters · filed 2025-05-08 | $57.80M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $10.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $35.00M derived: sum of 2 quarters · filed 2025-02-28 | $43.20M derived: sum of 3 quarters · filed 2025-02-28 | $51.20M 10-K · filed 2025-02-28 |
| 2023-09-30 | $24.20M 10-Q · filed 2024-11-05 | $32.40M derived: sum of 2 quarters · filed 2024-11-05 | $40.40M 10-Q · filed 2024-11-05 | |
| 2023-06-30 | $8.20M 10-Q · filed 2024-08-02 | $16.20M 10-Q · filed 2024-08-02 | ||
| 2023-03-31 | $8.00M 10-Q · filed 2024-05-03 | |||
| 2022-12-31 | $37.00M 10-K · filed 2024-02-28 | |||
| 2022-09-30 | $22.90M 10-Q · filed 2022-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |